Active Ingredient(s):Semaglutide FDA Approved: * September 20, 2019 Pharm Company: *NOVO NORDISK INC Category:Diabetes
Semaglutide, sold under the brand name Ozempic among others, is an antidiabetic medication used for the treatment of type 2 diabetes and long-term weight management.
Semaglutide acts like human glucagon-like peptide-1 (GLP-1) in that it increases insulin secretion, thereby increasing sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen, or as an oral form. One of its advantages over other antidia...
* May have multiple approval dates, manufacturers, or labelers.